Exploiting our knowledge of NF-κB signaling for the treatment of mammary cancer

Michael C. Haffner, Chiara Berlato, Wolfgang Doppler

Research output: Contribution to journalArticle

Abstract

Nuclear Factor-kappaB (NF-κB) has been implicated in the lobuloalveolar development of the mammary gland. In breast cancer its activation has been linked to tumor progression via stimulation of cell proliferation, pro-survival, and angiogenesis pathways and metastasis. Whether NF-κB activation in the immune system influences mammary cancer remains unclear. In addition to the constitutive activation frequently found in mammary carcinoma tissue, radio- and chemotherapeutic agents used in the treatment of mammary cancer can lead to activation of NF-κB. This effect has been postulated to contribute to the development of resistance to these agents and suggests the use of NF-κB inhibitors as sensitizers for therapy. The review describes principle targets and drugs used to inhibit NF-κB function and discusses future perspectives in the use of these inhibitors for the treatment of mammary cancer.

Original languageEnglish (US)
Pages (from-to)63-73
Number of pages11
JournalJournal of Mammary Gland Biology and Neoplasia
Volume11
Issue number1
DOIs
StatePublished - Jan 2006
Externally publishedYes

Fingerprint

Breast Neoplasms
Human Mammary Glands
Radio
Immune System
Cell Proliferation
Neoplasm Metastasis
Pharmaceutical Preparations
Neoplasms
Therapeutics

Keywords

  • Apoptosis
  • Breast cancer
  • Chemosensitization
  • Metastasis
  • NF-κB
  • Proteasome

ASJC Scopus subject areas

  • Cancer Research

Cite this

Exploiting our knowledge of NF-κB signaling for the treatment of mammary cancer. / Haffner, Michael C.; Berlato, Chiara; Doppler, Wolfgang.

In: Journal of Mammary Gland Biology and Neoplasia, Vol. 11, No. 1, 01.2006, p. 63-73.

Research output: Contribution to journalArticle

Haffner, Michael C. ; Berlato, Chiara ; Doppler, Wolfgang. / Exploiting our knowledge of NF-κB signaling for the treatment of mammary cancer. In: Journal of Mammary Gland Biology and Neoplasia. 2006 ; Vol. 11, No. 1. pp. 63-73.
@article{5405bb8a06b84e4fb10d2ed05f96891f,
title = "Exploiting our knowledge of NF-κB signaling for the treatment of mammary cancer",
abstract = "Nuclear Factor-kappaB (NF-κB) has been implicated in the lobuloalveolar development of the mammary gland. In breast cancer its activation has been linked to tumor progression via stimulation of cell proliferation, pro-survival, and angiogenesis pathways and metastasis. Whether NF-κB activation in the immune system influences mammary cancer remains unclear. In addition to the constitutive activation frequently found in mammary carcinoma tissue, radio- and chemotherapeutic agents used in the treatment of mammary cancer can lead to activation of NF-κB. This effect has been postulated to contribute to the development of resistance to these agents and suggests the use of NF-κB inhibitors as sensitizers for therapy. The review describes principle targets and drugs used to inhibit NF-κB function and discusses future perspectives in the use of these inhibitors for the treatment of mammary cancer.",
keywords = "Apoptosis, Breast cancer, Chemosensitization, Metastasis, NF-κB, Proteasome",
author = "Haffner, {Michael C.} and Chiara Berlato and Wolfgang Doppler",
year = "2006",
month = "1",
doi = "10.1007/s10911-006-9013-5",
language = "English (US)",
volume = "11",
pages = "63--73",
journal = "Journal of Mammary Gland Biology and Neoplasia",
issn = "1083-3021",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Exploiting our knowledge of NF-κB signaling for the treatment of mammary cancer

AU - Haffner, Michael C.

AU - Berlato, Chiara

AU - Doppler, Wolfgang

PY - 2006/1

Y1 - 2006/1

N2 - Nuclear Factor-kappaB (NF-κB) has been implicated in the lobuloalveolar development of the mammary gland. In breast cancer its activation has been linked to tumor progression via stimulation of cell proliferation, pro-survival, and angiogenesis pathways and metastasis. Whether NF-κB activation in the immune system influences mammary cancer remains unclear. In addition to the constitutive activation frequently found in mammary carcinoma tissue, radio- and chemotherapeutic agents used in the treatment of mammary cancer can lead to activation of NF-κB. This effect has been postulated to contribute to the development of resistance to these agents and suggests the use of NF-κB inhibitors as sensitizers for therapy. The review describes principle targets and drugs used to inhibit NF-κB function and discusses future perspectives in the use of these inhibitors for the treatment of mammary cancer.

AB - Nuclear Factor-kappaB (NF-κB) has been implicated in the lobuloalveolar development of the mammary gland. In breast cancer its activation has been linked to tumor progression via stimulation of cell proliferation, pro-survival, and angiogenesis pathways and metastasis. Whether NF-κB activation in the immune system influences mammary cancer remains unclear. In addition to the constitutive activation frequently found in mammary carcinoma tissue, radio- and chemotherapeutic agents used in the treatment of mammary cancer can lead to activation of NF-κB. This effect has been postulated to contribute to the development of resistance to these agents and suggests the use of NF-κB inhibitors as sensitizers for therapy. The review describes principle targets and drugs used to inhibit NF-κB function and discusses future perspectives in the use of these inhibitors for the treatment of mammary cancer.

KW - Apoptosis

KW - Breast cancer

KW - Chemosensitization

KW - Metastasis

KW - NF-κB

KW - Proteasome

UR - http://www.scopus.com/inward/record.url?scp=33748208181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748208181&partnerID=8YFLogxK

U2 - 10.1007/s10911-006-9013-5

DO - 10.1007/s10911-006-9013-5

M3 - Article

VL - 11

SP - 63

EP - 73

JO - Journal of Mammary Gland Biology and Neoplasia

JF - Journal of Mammary Gland Biology and Neoplasia

SN - 1083-3021

IS - 1

ER -